BioAge Labs

BioAge Labs is a clinical-stage company developing small-molecule drugs like apelin receptor agonists for obesity and metabolic diseases.
Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2024
Stage of Initial Investment
Series D
Initial Investment Year
2024
Bioage Portco Hover Image